Heterocyclic naphthoquinones derivatives for use in the treatment of cancers including Cushing disease
US11306063B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 7, 2017 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Dec 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention concerns heterocyclic naphthoquinones derivatives for use in the treatment of Cushing disease and other cancers, in particular via the inhibition of Ubiquitin Specific Proteases (USP) 8 and/or 2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.